Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

FGFR3/FGF9 Regulates the Activity of Profibrotic Cytokine and Growth Factor Pathways to Drive Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis (2018) Summa L, Thuong Trinh-Minh , Chen CW, Soare A, Distler O, Schett G, Distler J, et al. Conference contribution Fatty Lesions Detected on MRI Scans in Patients with Ankylosing Spondylitis Are Based on the Deposition of Fat in the Vertebral Bone Marrow (2018) Baraliakosi X, Boehm H, Samir A, Schett G, Braun J, Ramming A Conference contribution FATTY LESIONS DETECTED ON MRI SCANS IN PATIENTS WITH ANKYLOSING SPONDYLITIS ARE BASED ON THE DEPOSITION OF FAT IN THE VERTEBRAL BONE MARROW (2018) Baraliakos X, Boehm H, Barakat AS, Schett G, Braun J Conference contribution Inhibition of Nuclear Receptor Coactivator 3 Attenuates Fibrosis in Murine Models of Systemic Sclerosis (2018) Pötter S, Dees C, Bergmann C, Distler O, Schett G, Distler J, Ramming A Conference contribution Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from two phase 3 studies (FUTURE 2 and FUTURE 3) (2018) Wallman JK, Schett G, Mcinnes IB, Quebe-Fehling E, Rasouliyan L, Pricop L, Gaillez C, Fasth AE Conference contribution BIOMECHANICAL PROPERTIES OF RADIAL BONE ARE DIFFERENT BETWEEN AUTO-ANTIBODY POSITIVE AND NEGATIVE RHEUMATOID ARTHRITIS (2018) Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber A, Engelke K, et al. Conference contribution DIPEPTIDYL-PEPTIDASE-4 (DPP4) IS A POTENTIAL NEW MOLECULAR TARGET FOR TREATMENT OF FIBROSIS (2018) Soare AM, Gyoerfy H, Matei AE, Dees C, Zhang Y, Wohlfahrt T, Chen CW, et al. Conference contribution DIET INDUCED METABOLIC CHANGES IN AN OSTEOARTHRITIS MOUSE MODEL (2018) Huelser ML, Schreiyaeck C, Luo Y, Bozec A, Schett G, Mueller-Ladner U, Neumann E Conference contribution Does an 18f-FDG-PET/CT in Patients with Giant Cell Arteritis in Clinical Remission Make Sense? (2018) Schoenau V, Roth JP, Englbrecht M, Rech J, Schett G Conference contribution Durability of apremilast response through 5 years of treatment in subjects with psoriatic arthritis (2018) Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, et al. Conference contribution